Hormonal IUD (Mirena/Kyleena) for Teens: What the Transition to Adult Care Actually Looks Like

Why the Transition from Teen to Adult Care Matters for IUD Users

Changing from a pediatric or adolescent medicine provider to an adult OB-GYN or women's health NP is not just an administrative step. For a teen with a hormonal IUD, it is a window where care can fall through the cracks. Appointments lapse, replacement dates get missed, and confidentiality rules shift.

ACOG Committee Opinion 735 specifically addresses adolescent confidentiality during health system transitions and notes that failed handoffs can interrupt contraceptive continuity for young people. That interruption carries real reproductive consequences.

This article maps exactly what you need to know at each step.

Who Should Be Reading This

This guide is for you if you are:

• A teen between 12 and 17 (or a parent supporting one) who currently has a Mirena or Kyleena IUD
• Approaching the age at which your pediatrician, adolescent medicine specialist, or family medicine provider will refer you to adult gynecologic care
• Trying to understand what changes, what stays the same, and what you need to bring to your first adult appointment

It also applies to teens who got an IUD for reasons other than contraception, including heavy menstrual bleeding, dysmenorrhea, endometriosis-related pain, or PCOS-related cycle management.

What the Hormonal IUD Does in an Adolescent Body

How Mirena and Kyleena Work

Both devices release levonorgestrel (LNG) locally inside the uterus. Mirena releases approximately 20 mcg/day initially, tapering over time. Kyleena releases approximately 9 mcg/day initially. The primary mechanism is thickening cervical mucus so sperm cannot reach an egg. Systemic absorption is low, which is part of why both are considered appropriate for adolescents.

Sex-Specific Physiology in Teens

Adolescent uteruses are typically smaller than adult uteruses, and the cervix is less dilated, making insertion more uncomfortable. A 2019 review in the Journal of Pediatric and Adolescent Gynecology found that teens report higher procedural pain scores at insertion than adult users, though pain at one month post-insertion is similar.

Ovarian function is largely preserved with both devices. Most adolescents continue to ovulate, which matters because bone density accrual is still active in the teen years and depends on estrogen from normal follicular activity. Unlike depot medroxyprogesterone acetate (DMPA/Depo-Provera), the LNG-IUD does not suppress estrogen production and does not appear to compromise adolescent bone mineral density.

Menstrual Changes Teens Should Expect

Irregular spotting is common in the first 3 to 6 months with both devices. By 12 months:

• Roughly 20% of Kyleena users report amenorrhea (no period)
• Roughly 50% of Mirena users report amenorrhea at one year
• Most remaining users have lighter, shorter periods than before insertion

These changes are not harmful. They do not mean the device has stopped working or that something is wrong hormonally. Teens who received the IUD primarily to manage heavy menstrual bleeding (a common clinical indication in adolescents with conditions like von Willebrand disease or PCOS) may find this one of the most beneficial effects.

ACOG's Position on IUDs in Adolescents

ACOG Practice Bulletin 186 classifies long-acting reversible contraception (LARCs), including the LNG-IUD, as first-line contraceptive options for adolescents. The American Academy of Pediatrics echoes this position.

The historical concern that IUDs were unsafe for nulliparous teens (those who have not given birth) is not supported by current evidence. A 2017 systematic review published in Obstetrics and Gynecology found no increase in pelvic inflammatory disease risk in IUD users who were screened for STIs at insertion, regardless of age or parity.

Pelvic inflammatory disease risk is elevated only in the first 20 days after insertion and returns to baseline thereafter, provided initial STI screening was negative.

How the Transition to Adult Care Actually Works

What "Transition" Means in Practice

Most health systems define the pediatric-to-adult transition as occurring somewhere between ages 16 and 18, though state laws and insurance policies vary. Your current provider should ideally begin transition planning by age 14, per American Academy of Pediatrics guidance.

For IUD users, the practical tasks are:

1. Obtain a copy of your insertion records (device brand, lot number, insertion date, next-replacement date)
2. Know your STI screening history at insertion
3. Understand your device's expiration: Mirena is now approved for up to 8 years; Kyleena for up to 5 years
4. Identify your new adult provider before your next scheduled visit

Confidentiality and Consent Laws Change at 18

This is the single biggest source of confusion. Before 18, most states allow minors to consent to contraceptive services without parental involvement. After 18, you become the sole decision-maker and the sole person who can authorize release of your records.

If your records have been going to a parent or guardian, you now have the right to request that they come directly to you. Talk to your new provider's front desk about updating consent forms and insurance explanation-of-benefits routing.

What to Bring to Your First Adult Gynecology Appointment

• Your IUD insertion record (date, brand, size if noted, lot number)
• Your last STI screen results
• Any records of follow-up ultrasounds confirming placement
• A list of any medications you take (some antibiotics and antiretrovirals can interact with hormonal methods, though the LNG-IUD has fewer interactions than oral pills because systemic levels are so low)
• Your menstrual pattern notes, even informal ones from a period-tracking app

Pregnancy and Lactation Safety

If you are pregnant: The LNG-IUD is contraindicated in confirmed pregnancy. If pregnancy occurs with an IUD in place (which is rare, given >99% efficacy), there is an increased risk of ectopic pregnancy, septic miscarriage, and preterm birth. FDA prescribing information for Mirena states that the device should be removed as early as possible if intrauterine pregnancy is confirmed.

If you think you might be pregnant at any point during the transition period (gap in care, missed follow-up), take a home pregnancy test and contact a provider promptly.

Ectopic risk: Any teen presenting with lower abdominal pain and a positive pregnancy test while carrying an LNG-IUD needs immediate evaluation to rule out ectopic pregnancy.

Postpartum and lactation: The LNG-IUD is compatible with breastfeeding. Systemic LNG levels in breast milk are low and are not considered harmful to a nursing infant. ACOG and the CDC Medical Eligibility Criteria (MEC) classify LNG-IUD use during lactation as Category 1 or 2 (use generally acceptable), depending on timing after delivery.

For teens who become pregnant and then deliver, the IUD can be placed within 10 minutes of placental delivery (immediate postpartum) or at the standard 6-week postpartum visit. Immediate postpartum placement has a higher expulsion rate but remains effective for most users.

Fertility after removal: Fertility returns quickly after IUD removal, typically within the first menstrual cycle. There is no evidence of delayed fertility in adolescent users. This matters if a teen who had the IUD for non-contraceptive reasons (for example, menorrhagia management) later wants to conceive.

Non-Contraceptive Reasons Teens Use the LNG-IUD

Many adolescents receive a hormonal IUD for medical management rather than (or in addition to) contraception. This is worth understanding because your new adult provider needs to know the original indication to continue appropriate care.

Heavy Menstrual Bleeding and Blood Disorders

Von Willebrand disease affects approximately 1% of the general population and is one of the most common inherited bleeding disorders in adolescent girls presenting with heavy periods. The LNG-IUD is often prescribed in this group because it reduces menstrual blood loss by up to 90% in most users. Your new clinician should be told if a bleeding disorder was the original reason for your IUD.

PCOS-Related Cycle Management

In teens with polycystic ovary syndrome, irregular and sometimes heavy cycles can be managed with the LNG-IUD. It does not treat the underlying androgen excess or insulin resistance of PCOS, but it can control cycle-related symptoms. Your new provider may want to re-evaluate metabolic markers (fasting glucose, lipids, androgen levels) as part of your first adult visit if PCOS is part of your history.

Dysmenorrhea and Endometriosis

Endometriosis is frequently diagnosed late in adolescents. The LNG-IUD is a recognized treatment for endometriosis-associated pain and is endorsed for this use by ACOG Practice Bulletin 114. If your teen IUD was placed partly to manage pelvic pain, make sure your adult gynecologist knows this so they do not treat it as purely contraceptive.

What Changes (and What Does Not) After You Switch Providers

Here is a practical framework for the handoff, organized by what requires action versus what continues automatically:

Things That Continue Without Interruption

• IUD efficacy. The device does not stop working because your provider changed. As long as it is in place and within its approved duration, you are protected.
• Your menstrual pattern. Whatever cycle changes you experienced under adolescent care persist into adult care.
• The device's physical presence. No removal or replacement is required at the transition unless you are approaching the expiration date or have a clinical concern.

Things That Require Active Steps from You

• Scheduling your first adult gynecology appointment before a gap in care occurs. Aim for no more than a 6-month lapse from your last adolescent visit.
• Confirming your IUD's expiration date with your new provider in the first visit.
• Updating consent forms so your health information goes to you, not a parent or guardian (after age 18).
• Deciding whether to continue with the same device or switch to a different method. Your new provider cannot assume you want to continue; they need your informed, current consent.
• STI screening. The CDC recommends annual chlamydia and gonorrhea screening for all sexually active females under 25. CDC 2021 STI Treatment Guidelines list this as a routine standard regardless of contraceptive method.

Things That May Change

• Your insurance coverage. At 18 (or sometimes 26, depending on parental plan rules), your coverage source may change. Mirena and Kyleena are covered without cost-sharing under the ACA's contraceptive mandate for most plans. Confirm coverage before a scheduled replacement.
• Who can see your health information. HIPAA privacy rights fully transfer to you at 18.

Who This Is Right For, and Who Should Discuss Alternatives

Right for You If

• You are an adolescent (any age from menarche) seeking highly effective, low-maintenance contraception
• You have heavy menstrual bleeding, dysmenorrhea, or endometriosis-related pain and want hormonal management without a daily pill
• You have PCOS with cycle irregularities
• You have a bleeding disorder and need menstrual suppression
• You are entering a period of life transition (heading to college, moving cities) and want a method that does not require a daily routine

Discuss Carefully If

• You have a current pelvic or cervical infection (absolute contraindication to insertion)
• You have unexplained uterine or cervical abnormalities
• You are already pregnant (absolute contraindication)
• You have current STI symptoms (delay insertion until treated and re-screened)
• You have a history of breast cancer (relative contraindication, given progestogen exposure)

The WHO Medical Eligibility Criteria for Contraceptive Use provides the full categorization of conditions affecting LNG-IUD eligibility.

Talking to Your New Provider: A Script That Works

Many teens feel uncertain about what to say at a first adult gynecology appointment. Here is a direct approach that covers what clinicians need:

"I have a [Mirena/Kyleena] IUD that was inserted on [date]. It's been in for [X years]. I originally got it for [contraception/heavy periods/PCOS/endometriosis/other]. My last STI screen was in [month/year] and it was negative. I want to confirm the placement is still correct and find out when I need to schedule a replacement."

That one paragraph gives your new provider the device history, the original indication, the safety screening history, and the forward plan. It also signals that you are an informed patient, which shapes how clinicians approach the appointment.

Evidence Gaps and What Is Extrapolated

Women and adolescents have been historically underrepresented in contraceptive pharmacology trials. Most LNG-IUD efficacy data comes from trials enrolling predominantly adult women. The adolescent-specific data, while growing, relies on smaller cohorts.

A 2020 Cochrane review on IUD use in adolescents noted that continuation rates in teens are high when insertion is performed with adequate pain management and counseling, but that more data on long-term bone outcomes in younger adolescents (under 15) would strengthen recommendations. Current guidance is largely extrapolated from adult efficacy data combined with adolescent-specific safety studies.

This honesty matters: the device works well in teens based on the evidence we have, and no signal of harm unique to adolescent users has emerged, but some questions remain open.

What Happens When Your Device Expires During the Transition

Mirena is approved for up to 8 years. Kyleena is approved for up to 5 years. If your device was inserted at age 14 and you are using Kyleena, it will expire by age 19. That expiration may land right in the middle of your transition window.

Do not let the transition delay device replacement. An expired IUD provides no reliable contraceptive protection. Schedule the replacement with your new adult provider as your first priority if you are within 6 months of the expiration date.

Replacement is typically faster and less painful than the original insertion for most users, though teen users with a small cervical os may still find it uncomfortable. Talk to your provider about pre-procedural pain management options: ibuprofen 600-800 mg taken 1 hour before, cervical softening agents (misoprostol), or in some settings, paracervical block or procedural sedation.